HOX4 Antibody

What are HOX4 proteins and why are they important research targets?

HOX4 proteins belong to a family of homeodomain-containing transcription factors that play essential roles in embryonic development by providing cells with specific positional identities along the anterior-posterior axis. They function as sequence-specific DNA-binding proteins that regulate the expression of developmental target genes . HOX4 proteins bind to specific DNA sequences, with high-affinity binding sites having the consensus sequence 5'-TAATGA[CG]-3' and low-affinity binding sites having the sequence 5'-CTAATTTT-3' . Their importance extends beyond embryonic development, as dysregulation of HOX genes has been implicated in various pathological conditions, particularly cancer development and progression .

How do I choose between different HOX4 antibodies (HOXA4, HOXB4, HOXC4)?

Selection of the appropriate HOX4 antibody depends on several factors:

• Specific paralog target: Determine which HOX4 paralog (HOXA4, HOXB4, HOXC4, HOXD4) is relevant to your research question based on expression patterns in your tissue/cells of interest .

• Species reactivity: Verify cross-reactivity with your experimental model. For example, the I12 anti-Hoxb4 antibody shows reactivity with human, mouse, and rat samples but not chicken .

• Application compatibility: Consider validated applications:

  • HOXA4 antibody (ab131049): Suitable for IHC-P, WB, ICC/IF

  • HOXB4 antibody (I12): Recommended for immunohistochemistry and Western blot

  • HOXC4 antibody (14321-1-AP): Validated for WB applications

• Confirmed specificity: Review validation data provided by manufacturers or published literature to ensure the antibody recognizes your target specifically .

What are the key differences in expression patterns between HOXA4, HOXB4, and HOXC4?

HOX4 paralogs exhibit distinct spatial and temporal expression patterns that correlate with their developmental functions:

• HOXA4: Expressed during embryonic development with roles in anterior-posterior patterning. In adults, expression has been associated with endometrial cancer prognosis (higher expression correlates with poor prognosis) .

• HOXB4: Critical for hindbrain segmentation and limb development. Plays a role in the establishment of rhombomere boundaries during neural development . HOXB4 expression can be induced by retinoic acid treatment during development .

• HOXC4: Not expressed in normal prostate tissue but commonly detected in prostate cancers . Also expressed in germinal center B cells and upregulated by stimuli that induce AID expression (LPS, CD154, and IL-4) . HOXC4 has been identified as a potential biomarker in prostate cancer diagnostic panels .

Understanding these expression patterns is crucial when interpreting experimental results and when choosing the appropriate antibody for specific tissue or developmental contexts.

What are the optimal protocols for using HOX4 antibodies in immunohistochemistry?

For optimal immunohistochemistry (IHC) results with HOX4 antibodies:

Sample preparation:

• Use formalin-fixed paraffin-embedded (FFPE) sections (4-6 μm thickness)

• For HOXA4 antibody (ab131049): Validated at 1μg/ml concentration on human mammary cancer tissue

Protocol outline:

• Deparaffinize and rehydrate sections

• Perform antigen retrieval (citrate buffer pH 6.0 recommended)

• Block endogenous peroxidase (3% H₂O₂) and non-specific binding (5% normal serum)

• Apply primary antibody at optimized dilution:

  • HOXA4 antibody: 1μg/ml

  • HOXB4 antibody: Follow manufacturer recommendations

• Incubate overnight at 4°C

• Apply appropriate detection system based on host species

• Counterstain, dehydrate, and mount

Controls:

• Include known positive tissue controls (based on expected expression patterns)

• Include antibody negative controls (omitting primary antibody)

• Consider using tissues from knockout models when available for specificity validation

How should Western blot protocols be optimized for HOX4 protein detection?

For optimal Western blot detection of HOX4 proteins:

Sample preparation:

• Extract proteins using buffers that preserve nuclear proteins (HOX4 proteins are nuclear transcription factors)

• For total protein extraction from tissues or cells, use NE-PER Nuclear and Cytoplasmic Extraction Kit or similar

Protocol optimization:

• Load 20-40 μg protein per lane

• Use 10-12% SDS-PAGE gels for optimal resolution

• Apply primary antibodies at recommended dilutions:

  • HOXA4 antibody (ab131049): 0.5 μg/mL

  • HOXC4 antibody (14321-1-AP): 1:5000-1:50000

• Expected molecular weights:

  • HOXA4: 34 kDa (predicted)

  • HOXC4: 30 kDa (calculated), 39 kDa (observed)

• Cell lines for positive controls:

  • HOXA4: SW620 and PC-12 cells

  • HOXC4: Jurkat cells, PC-12 cells, U-251 cells

• Optimize incubation times and washing steps based on signal strength and background

Troubleshooting tips:

• If detecting multiple bands, verify specificity using peptide competition assays

• Nuclear enrichment may be necessary to enhance detection of low-abundance HOX proteins

• For challenging targets, consider enhanced chemiluminescence detection systems

How can I validate the specificity of a HOX4 antibody in my experimental system?

Validating antibody specificity is crucial for reliable research findings. For HOX4 antibodies:

Multiple validation approaches:

• Genetic validation:

  • Use cells/tissues with genetic knockout or knockdown of the target HOX4 gene

  • Compare with wild-type samples to confirm absence of signal in knockout/knockdown samples

• Peptide competition:

  • Pre-incubate antibody with immunizing peptide (if available)

  • Signal should be significantly reduced or eliminated in competed samples

• Multiple antibody comparison:

  • Test different antibodies targeting distinct epitopes of the same HOX4 protein

  • Consistent results across antibodies increase confidence in specificity

• Expression pattern validation:

  • Verify that detected expression patterns match known HOX4 expression domains from published literature

  • For example, HOXB4 expression in specific rhombomeres during hindbrain development

• Cross-reactivity assessment:

  • Test against related HOX proteins, particularly those with high sequence homology

  • Use peptide microarray technology (like that described in the Histone Antibody Specificity Database) to systematically evaluate cross-reactivity

How does epitope masking affect HOX4 antibody performance in different applications?

Epitope masking can significantly impact HOX4 antibody performance due to several factors:

Mechanisms of epitope masking:

• Protein-protein interactions:

  • HOX4 proteins function as transcription factors and interact with numerous cofactors

  • These interactions may block antibody access to specific epitopes

  • For example, HOX4 interactions with DNA or other transcriptional regulators may mask epitopes in native conditions

• Post-translational modifications (PTMs):

  • PTMs can alter epitope recognition

  • For fixed tissue applications, consider that formalin fixation may create protein cross-links that mask epitopes, necessitating appropriate antigen retrieval methods

• Conformation-dependent recognition:

  • Some antibodies recognize conformational epitopes that may be lost in denatured conditions

  • Others recognize linear epitopes that may be inaccessible in native conditions

Practical recommendations:

• For immunoprecipitation: Use antibodies raised against surface-exposed epitopes

• For Western blot: Select antibodies recognizing denaturation-resistant epitopes

• For IHC/ICC: Optimize antigen retrieval methods (heat-induced or enzymatic) to expose masked epitopes

• For challenging applications: Consider using multiple antibodies targeting different epitopes

What are the most common sources of false positives in HOX4 antibody experiments and how can they be minimized?

Common sources of false positives in HOX4 antibody experiments include:

Cross-reactivity issues:

• HOX proteins share significant sequence homology, especially in the homeodomain

• Solution: Verify antibody specificity using peptide competition assays or testing in systems with knockout/knockdown of the target HOX4 gene

Non-specific binding:

• Secondary antibody binding to endogenous immunoglobulins in tissue

• Solution: Include proper blocking steps and consider using isotype controls

Signal amplification artifacts:

• Excessive amplification can produce non-specific signals

• Solution: Titrate primary antibody and optimize detection system parameters

Endogenous peroxidase activity (for IHC):

• Solution: Include proper quenching steps (3% H₂O₂ treatment)

Autofluorescence (for IF):

• Solution: Include appropriate quenching steps and controls to distinguish specific signal from autofluorescence

Mitigation strategies:

• Include appropriate negative controls (no primary antibody, isotype controls)

• Use positive controls with known expression patterns

• Validate with orthogonal methods (e.g., mRNA expression)

• Consider using multiple antibodies targeting different epitopes

• Use appropriate blocking reagents to reduce non-specific binding

How should HOX4 antibodies be stored and handled to maintain optimal performance?

Proper storage and handling of HOX4 antibodies is crucial for maintaining their functionality:

Storage recommendations:

• Store antibodies at -20°C for long-term storage (most HOX4 antibodies)

• For short-term use (up to two weeks), 4°C storage is acceptable

• Avoid repeated freeze-thaw cycles by preparing small aliquots (≥20 μl)

• For concentrate or bioreactor products, consider adding equal volume of glycerol as cryoprotectant before freezing

Handling practices:

• Thaw antibodies on ice when removing from freezer

• Mix gently by flicking or gentle inversion (avoid vortexing)

• Briefly centrifuge before opening to collect solution at bottom

• Use sterile technique when handling stock solutions

• Return to appropriate storage conditions immediately after use

Stability considerations:

• Check manufacturer's recommendations for shelf-life at different storage temperatures

• Some HOX4 antibodies (like HOXC4 antibody 14321-1-AP) are supplied in storage buffer containing 0.02% sodium azide and 50% glycerol at pH 7.3 for enhanced stability

• HOXC4 antibody is reported stable for one year after shipment when stored at -20°C

How are HOX4 antibodies used to study developmental processes and segmentation?

HOX4 antibodies have been instrumental in understanding developmental processes, particularly segmentation mechanisms:

Hindbrain development studies:

• HOXB4 antibodies have revealed that Hox4 proteins regulate the establishment of rhombomere boundaries in the developing hindbrain

• Research has shown that Hox4 proteins can drive cell segregation and control the expression of multiple cell adhesion/repulsion genes

• Antibodies have helped demonstrate that ectopic expression of Hoxb4 suppresses boundaries between rhombomeres by regulating genes like Lrrtm3 and Epha7

Limb development research:

• HOX4 antibodies have been used to investigate how Hox genes regulate the onset of Tbx5 expression in the forelimb

• Immunostaining with Hoxb4 antibodies has helped elucidate the spatiotemporal expression patterns critical for limb positioning

Methodological approaches:

• Whole-mount immunohistochemistry to visualize expression domains

• Double immunofluorescence to study co-localization with other developmental markers

• Time-course analyses to track dynamic expression changes during development

• Combining with genetic manipulations (e.g., retinoic acid treatment) to study regulation

What is the role of HOX4 expression in cancer research and how are antibodies used in this context?

HOX4 genes have emerged as important markers and potential drivers in cancer, with antibodies playing key roles in this research:

Cancer associations:

• HOXA4: Higher expression associated with poor prognosis in endometrial cancer

• HOXC4: Part of gene panels that identify patients with aggressive prostate cancer and predict recurrence

• HOX4 genes: Altered expression patterns observed in renal, endometrial, glioma, lung, liver, colorectal, head and neck, and ovarian cancers

Research applications:

• Diagnostic biomarker development:

  • HOXC4 and HOXC6 are included in multi-gene panels for prostate cancer diagnosis and prognosis

  • Antibodies enable protein-level validation of gene expression findings

• Cancer mechanisms investigation:

  • Study of HOX4 proteins in cancer cell lines helps elucidate their roles in proliferation, invasion, and metastasis

  • Example: Reduction of HOXC protein levels reduces proliferation of prostate cancer cell lines

• Expression profiling:

  • HOX4 antibodies used in tissue microarrays to correlate expression with clinical outcomes

  • IHC staining of tumor samples helps establish prognostic significance

• Target validation:

  • Western blotting with HOX4 antibodies confirms knockdown efficiency in functional studies

  • Supports investigation of HOX4 proteins as potential therapeutic targets

How do HOX4 expression patterns correlate with prognosis in different malignancies?

HOX4 expression patterns show significant correlations with cancer prognosis across multiple malignancies:

Acute Myeloid Leukemia (AML):

• Downregulated HOX expression is a consistent feature of favorable AML subtypes

• HOX overexpression is associated with nucleophosmin (NPM) mutations in certain AML subsets

• HOXA9 levels (a HOX family member) are significantly inversely correlated with survival

Prostate Cancer:

• HOXC4 is part of an 8-gene panel developed by Leyten et al. that can identify patients with aggressive prostate cancer

• HOXC4 and HOXC6 are included in panels (16-gene and 5-gene) that predict prostate cancer recurrence after treatment

Renal Cancer:

• According to The Human Protein Atlas data cited in the search results, HOX expression shows opposing correlations with prognosis:

  • Poor prognosis associated with higher levels of HOXA3, HOXA11, HOXC6, HOXC8, and HOXD10

  • Favorable prognosis associated with increased levels of HOXA6, HOXA7, and HOXB8

Endometrial Cancer:

• Poor prognosis associated with higher expression of HOXA4, HOXA5, HOXA6, HOXA7, and HOXB9

• Favorable prognosis associated with higher expression of HOXB5 and HOXB6

Other Cancers:

• Increased expression of HOX proteins has been associated with poor prognosis in glioma, lung, liver, colorectal, head and neck, and ovarian cancers

How can ChIP-seq be optimized using HOX4 antibodies to identify genome-wide binding sites?

Optimizing ChIP-seq with HOX4 antibodies requires careful consideration of several technical aspects:

Antibody selection for ChIP applications:

• Choose ChIP-validated antibodies or validate new antibodies specifically for ChIP applications

• Test antibody efficiency in immunoprecipitating the target HOX4 protein before proceeding to sequencing

• Consider using monoclonal antibodies for higher specificity, though well-validated polyclonal antibodies may provide better epitope coverage

Protocol optimization:

• Crosslinking optimization:

  • For HOX4 proteins (transcription factors), standard 1% formaldehyde for 10 minutes is typically sufficient

  • Consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde for improved capture of protein-protein interactions

• Sonication parameters:

  • Optimize sonication conditions to generate DNA fragments of 200-500bp

  • Verify fragment size distribution by agarose gel electrophoresis

• Immunoprecipitation conditions:

  • Use 3-5μg of antibody per ChIP reaction

  • Include appropriate controls:

    • Input DNA (pre-immunoprecipitation)

    • IgG control (matching the species of the HOX4 antibody)

    • If possible, include samples from cells with HOX4 knockout/knockdown

• Data analysis considerations:

  • Analyze enrichment at known HOX4 binding motifs (5'-TAATGA[CG]-3' and 5'-CTAATTTT-3')

  • Compare binding sites with gene expression data to identify functional targets

  • Consider the possibility of indirect binding through protein complexes

What strategies exist for multiplexing HOX4 antibodies with other markers in immunofluorescence studies?

Advanced multiplexing strategies for HOX4 antibodies enable comprehensive analysis of developmental contexts and cancer tissues:

Technical approaches for multiplexing:

• Traditional sequential immunofluorescence:

  • Use HOX4 antibodies from different host species (e.g., rabbit anti-HOXA4, rat anti-HOXB4)

  • Pair with spectrally distinct fluorophore-conjugated secondary antibodies

  • Carefully control for cross-reactivity between antibodies

• Tyramide signal amplification (TSA) multiplexing:

  • Allows use of multiple primary antibodies from the same species

  • Process:

    1. Apply first primary antibody (e.g., rabbit anti-HOXA4)

    2. Detect with HRP-conjugated secondary and TSA-fluorophore

    3. Strip or inactivate antibodies while preserving fluorophore signal

    4. Repeat with next primary antibody (e.g., rabbit anti-HOXC4)

  • Enables detection of low-abundance HOX4 proteins alongside other markers

• Sequential multiplex immunohistochemistry:

  • Apply serial rounds of staining, imaging, and antibody stripping

  • Particularly useful for tissue microarrays in cancer research

  • Allows correlation of HOX4 expression with multiple cancer markers

• Advanced platforms:

  • Consider mass cytometry (CyTOF) using metal-conjugated antibodies for highly multiplexed detection

  • For tissue sections, imaging mass cytometry or multiplexed ion beam imaging (MIBI) provide spatial resolution with high-parameter capability

Biological applications:

• Study HOX4 proteins alongside cell type-specific markers in development

• Investigate co-expression with other transcription factors in gene regulatory networks

• Analyze HOX4 expression in relation to proliferation markers in cancer samples

How can HOX4 antibodies be integrated into single-cell analysis workflows?

Integrating HOX4 antibodies into single-cell analysis provides unprecedented insights into developmental processes and disease heterogeneity:

Single-cell protein analysis approaches:

• Flow cytometry and FACS:

  • Requires permeabilization protocols optimized for nuclear transcription factors

  • May combine surface markers with intracellular HOX4 staining

  • Useful for isolating specific cell populations based on HOX4 expression

  • Protocol considerations:

    • Use paraformaldehyde fixation followed by methanol or saponin permeabilization

    • Include appropriate isotype controls

    • Consider fluorescence-minus-one (FMO) controls

• CITE-seq and related technologies:

  • Combine antibody detection with single-cell RNA sequencing

  • May use oligo-tagged HOX4 antibodies alongside other markers

  • Provides correlation between protein and mRNA at single-cell resolution

  • Particularly valuable for studying developmental transitions where protein and mRNA dynamics may differ

• Imaging-based single-cell analysis:

  • Imaging mass cytometry with HOX4 antibodies provides spatial context

  • Single-cell resolution immunofluorescence with image cytometry analysis

  • Digital spatial profiling for region-specific quantification

  • Cyclic immunofluorescence for high-parameter imaging

Data integration strategies:

• Correlate HOX4 protein levels with transcriptomic data from the same cells

• Create multi-omic profiles incorporating HOX4 protein expression

• Map HOX4-expressing cells to developmental trajectories

• Identify rare cell populations with unique HOX4 expression patterns

Applications in developmental biology:

• Track HOX4 expression during embryonic patterning with single-cell resolution

• Study the role of HOX4 in establishing positional identity in different cell lineages

• Investigate HOX4 expression dynamics during cell fate transitions

How are HOX4 antibodies being used to study the role of these proteins in cell segregation and boundary formation?

Recent research has revealed HOX4 proteins' critical roles in cell segregation and boundary formation, with antibodies enabling key discoveries:

Current research findings:

• HOX4 proteins (particularly Hoxb4) have been shown to drive cell segregation and regulate non-autonomous apical remodeling

• Ectopic expression of Hoxb4 can suppress rhombomere boundaries in the developing hindbrain

• Interfaces between Hox4-expressing and non-expressing cells are sufficient to trigger morphological and molecular features of rhombomere boundaries

Mechanistic insights:

• HOX4 proteins regulate multiple cell adhesion/repulsion genes, including:

  • Epha4, ephrin A5, and ephrin B2 (repressed by Hoxb4)

  • Lrrtm3 (upregulated by Hoxb4 in dorsal r7)

  • Epha7 (repressed by Hoxb4 in r7)

• These regulatory relationships ensure differential gene expression across boundaries (e.g., r6/r7 boundary)

Antibody applications in this research:

• Immunostaining to visualize Hox4 protein distribution at boundaries

• Validation of ectopic expression in electroporation experiments

• Analysis of cellular behaviors at HOX4-expressing/non-expressing interfaces

• Confirmation of target gene expression changes following HOX4 manipulation

Future research directions:

• Investigation of HOX4-mediated regulation of cytoskeletal dynamics

• Analysis of HOX4 interactions with other boundary-regulating transcription factors

• Exploration of HOX4 roles in tissue boundary formation beyond the hindbrain

What are the latest findings on HOX4 proteins in stem cell research and regenerative medicine?

HOX4 proteins play significant roles in stem cell biology, with antibodies facilitating key discoveries in this field:

Stem cell regulation:

• HOXB4 has been identified as an important regulator of hematopoietic stem cell self-renewal and expansion

• Expression of HOXB4 in hematopoietic progenitors enhances their repopulating capacity

• HOX4 proteins may influence stem cell niche interactions through regulation of adhesion molecules

Regenerative medicine applications:

• Modulation of HOX4 expression is being explored to enhance stem cell expansion protocols

• HOXB4-overexpressing stem cells show improved engraftment in transplantation models

• Understanding HOX4 regulation may improve directed differentiation protocols

Antibody applications in stem cell research:

• Tracking HOX4 expression during differentiation protocols

• Isolating specific stem/progenitor populations based on HOX4 expression

• Validating genetic manipulation of HOX4 in stem cell engineering

• Correlating HOX4 expression with functional stem cell properties

Emerging research areas:

• Role of HOX4 proteins in induced pluripotent stem cell (iPSC) generation and differentiation

• HOX4 functions in tissue-specific stem/progenitor populations

• Development of small molecules targeting HOX4 pathways for regenerative applications

How can contradictory findings about HOX4 function in different experimental systems be reconciled?

Researchers often encounter contradictory findings regarding HOX4 function across different experimental systems, requiring careful interpretation:

Sources of contradictory findings:

• Context-dependent functions:

  • HOX4 proteins often exhibit different activities depending on cellular context

  • For example, HOXC4 is not expressed in normal prostate tissue but is upregulated in prostate cancer

  • HOX4 proteins may have different effects in embryonic versus adult tissues

• Paralog-specific versus redundant functions:

  • Different HOX4 paralogs (HOXA4, HOXB4, HOXC4, HOXD4) may have overlapping or distinct functions

  • Research has shown that while Hox proteins share common potential to induce cell segregation, this activity can be masked or modulated in some contexts

• Methodological differences:

  • Antibody specificity issues between studies

  • Variations in experimental models (cell lines, primary tissues, in vivo systems)

  • Differences in HOX4 overexpression levels or knockdown efficiency

Reconciliation strategies:

• Systematic comparison:

  • Use identical antibodies and protocols across different systems

  • Perform side-by-side comparisons of different HOX4 paralogs

  • Validate findings using multiple independent approaches

• Cofactor analysis:

  • Investigate differential expression of HOX cofactors (PBX, MEIS) across systems

  • Map cofactor binding and interaction profiles

• Developmental timing considerations:

  • Carefully control for developmental stage when comparing results

  • Consider dynamic changes in HOX4 function over developmental time

• Genetic background effects:

  • Account for strain/genetic background differences in animal models

  • Consider cell line-specific genetic aberrations when using cancer cell lines

Case example:

• Studies of Hoxb4 in hindbrain development show it can both enforce boundaries (endogenously) and suppress boundaries (when ectopically expressed)

• This apparent contradiction can be reconciled by understanding that HOX4 proteins function primarily by establishing differential gene expression across territories, rather than having fixed "pro-boundary" or "anti-boundary" activities

By employing these strategies, researchers can better understand the complex and context-dependent functions of HOX4 proteins across different biological systems.

What are the validated application protocols for different commercial HOX4 antibodies?

What DNA-binding motifs are recognized by different HOX4 proteins?

What key resources are available for HOX4 antibody validation and research?